Suchergebnisse - "Meriranta, Leo"

PubPharm (17)

1

Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-cell Lymphoma

enthalten in: Blood cancer discovery | 2024

von Meriranta, L. | Sorri, S. | Huse, K. | +12

2

Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas

enthalten in: Med (New York, N.Y.) | 2024

von Arffman, M. | Meriranta, L. | Autio, M. | +13

3

MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma : the Nordic Lymphoma Group MCL7 VALERIA trial

enthalten in: Blood advances | 2024

von Jerkeman, M. | Kolstad, A. | Hutchings, M. | +12

4

Blood has never been thicker : Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas

enthalten in: Seminars in hematology | 2023

von Meriranta, L. | Pitkänen, E. | Leppä, S.

5

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

enthalten in: Blood | 2022

von Meriranta, L. | Alkodsi, A. | Pasanen, A. | +17

CommentIn: Blood. 2022 Mar 24;139(12):1780-1781. - PMID 35323879

6

The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma

enthalten in: EJHaem | 2021

von Isaksen, K. | Beiske, K. | Smeland, E. | +10

7

The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma

enthalten in: eJHaem | 2021

von Isaksen, K. | Beiske, K. | Smeland, E. | +10

8

Immunogenomic landscape of hematological malignancies

enthalten in: bioRxiv.org | 2020

von Dufva, O. | Pölönen, P. | Brück, O. | +13

9

Immunogenomic Landscape of Hematological Malignancies

enthalten in: Cancer cell | 2020

von Dufva, O. | Pölönen, P. | Brück, O. | +22

CommentIn: Cancer Cell. 2020 Sep 14;38(3):313-316. - PMID 32931741

10

Immunogenomic Landscape of Hematological Malignancies

enthalten in: Cancer cell | 2020

von Dufva, O. | Pölönen, P. | Brück, O. | +22

ErratumFor: Cancer Cell. 2020 Sep 14;38(3):380-399.e13. - PMID 32649887